Welcome to the Pharmacy Benefit Brief. This brief is your monthly snapshot of news from America’s prescription drug supply chain including pharmacy benefit managers, independent pharmacies, and drug manufacturers. Pandemic Vaccine: Safety Top Priority for Rx Supply Chain… As states
While debating important legislative proposals that can impact patients’ health and access to medications, the discussion should rely on solid facts and evidence. Today, we’re highlighting new reputable third-party research and analyses by economists which underscore that legislation focused on
PBMs recognize home delivery can provide an alternative way of safely accessing prescribed medications. To promote expanded access to home delivery, PBMs are temporarily waiving requirements for pharmacies to obtain proof-of-receipt signatures from patients, unless required by law. Because
In case you missed it, the Brookings Institution released a new analysis, “A Brief Look At Current Debates About Pharmacy Benefit Managers,” which provides an overview of recent legislation targeting pharmacy benefit companies being considered by Congress and how the
Claire Winiarek is Vice President, Policy for PCMA. In this role, she leads the association’s policy development activities in support of the industry’s federal and state legislative and regulatory advocacy efforts. Prior to joining PCMA, Claire served as the Director
As the uncertain and unceasing public health care crisis brought on by COVID-19 rages on, it is more important than ever for American families to have access to quality, affordable health care, regardless of where they live. At Employers Health,
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) applauds the recent ruling by the U.S. Court of Appeals for the Tenth Circuit in PCMA v. Mulready. In a unanimous decision, the court sustained PCMA’s challenge to four provisions of
Randy Kane Senior Manager, State Affairs Randy Kane is Senior Manager, State Affairs for PCMA. In this role he provides support and coordination on state activity and develops materials for the state affairs team and our members. Previously, Mr. Kane
Economists Explain Policies Restricting Pharmacy Benefits Will Lead To Higher Costs, Less Competition, And Fewer Choices For Employers In case you missed it, Joe Grogan, visiting senior fellow at the USC Schaeffer Center and former White House domestic policy adviser,
©2024 PCMA. All Rights Reserved.
